HomeTERN • NASDAQ
add
Terns Pharmaceuticals Inc
Previous close
$52.72
Day range
$52.72 - $52.84
Year range
$1.87 - $53.19
Market cap
6.09B USD
Avg Volume
6.29M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 27.60M | 6.35% |
Net income | -23.57M | -8.13% |
Net profit margin | — | — |
Earnings per share | -0.24 | 0.00% |
EBITDA | -27.59M | -6.58% |
Effective tax rate | -1.65% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.02B | 184.50% |
Total assets | 1.03B | 181.67% |
Total liabilities | 18.55M | 2.74% |
Total equity | 1.01B | — |
Shares outstanding | 115.41M | — |
Price to book | 5.88 | — |
Return on assets | -10.40% | — |
Return on capital | -10.68% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -23.57M | -8.13% |
Cash from operations | -19.08M | -30.85% |
Cash from investing | -350.00M | -270.97% |
Cash from financing | 743.12M | 244,347.04% |
Net change in cash | 374.05M | 444.12% |
Free cash flow | -13.33M | -46.17% |
About
Founded
2016
Headquarters
Website
Employees
59
